JIN MEDICAL Valuation
| ZJYL Stock | 1.07 0.06 5.94% |
Today, the firm appears to be fairly valued. JIN MEDICAL INTERNATIONAL retains a regular Real Value of USD1.03 per share. The prevalent price of the firm is USD1.07. Our model calculates the value of JIN MEDICAL INTERNATIONAL from analyzing the firm fundamentals such as return on equity of 0.11, and Return On Asset of 0.0403 as well as examining its technical indicators and probability of bankruptcy. Key fundamental drivers impacting JIN MEDICAL's valuation include:
Price Book 6.3826 | Enterprise Value 151.5 M | Enterprise Value Ebitda 58.1528 | Price Sales 8.3232 | Trailing PE 53.5 |
Fairly Valued
Today
Please note that JIN MEDICAL's price fluctuation is abnormally volatile at this time. Calculation of the real value of JIN MEDICAL INTERNATIONAL is based on 3 months time horizon. Increasing JIN MEDICAL's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the JIN stock is determined by what a typical buyer is willing to pay for full or partial control of JIN MEDICAL INTERNATIONAL. Since JIN MEDICAL is currently traded on the exchange, buyers and sellers on that exchange determine the market value of JIN Stock. However, JIN MEDICAL's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 1.07 | Real 1.03 | Hype 0.92 | Naive 0.68 |
The intrinsic value of JIN MEDICAL's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence JIN MEDICAL's stock price.
Estimating the potential upside or downside of JIN MEDICAL INTERNATIONAL helps investors to forecast how JIN stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of JIN MEDICAL more accurately as focusing exclusively on JIN MEDICAL's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use JIN MEDICAL's intrinsic value based on its ongoing forecasts of JIN MEDICAL's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against JIN MEDICAL's closest peers.
JIN MEDICAL Cash |
|
JIN Valuation Trend
Knowing JIN MEDICAL's actual value is paramount for traders when making sound investment determinations. Using both JIN MEDICAL's enterprise value as well as its market capitalization is the best way to estimate the value of the company and is usually enough for investors to make market timing decisions.
JIN MEDICAL Total Value Analysis
JIN MEDICAL INTERNATIONAL is at this time anticipated to have valuation of 151.47 M with market capitalization of 167.51 M, debt of 4.11 M, and cash on hands of . Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the JIN MEDICAL fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
151.47 M | 167.51 M | 4.11 M |
JIN MEDICAL Investor Information
About 76.0% of the company outstanding shares are owned by insiders. The company had not issued any dividends in recent years. JIN MEDICAL INTERNATIONAL had 20:1 split on the 8th of February 2024. Based on the analysis of JIN MEDICAL's profitability, liquidity, and operating efficiency, JIN MEDICAL INTERNATIONAL is doing better financially today then in previous quarter. It has a moderate probability of reporting better financial numbers in December.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.18 | 0.17 |
|
| |||||
| Operating Income | 2.3 M | 2.6 M |
|
|
JIN MEDICAL Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. JIN MEDICAL has an asset utilization ratio of 60.24 percent. This suggests that the Company is making USD0.6 for each dollar of assets. An increasing asset utilization means that JIN MEDICAL INTERNATIONAL is more efficient with each dollar of assets it utilizes for everyday operations.JIN MEDICAL Ownership Allocation
JIN MEDICAL INTERNATIONAL has a total of 156.55 Million outstanding shares. JIN MEDICAL retains majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.84 (percent) of JIN MEDICAL outstanding shares that are owned by insiders attests that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company holds, if the real value of the firm is less than the current market value, you may not be able to make money on it.JIN MEDICAL Profitability Analysis
The company reported the previous year's revenue of 19.82 M. Net Income was 2.88 M with profit before overhead, payroll, taxes, and interest of 6.36 M.About JIN MEDICAL Valuation
We use absolute and relative valuation methodologies to arrive at the intrinsic value of JIN MEDICAL INTERNATIONAL. In general, an absolute valuation paradigm, as applied to this company, attempts to find the value of JIN MEDICAL INTERNATIONAL based exclusively on its fundamental and basic technical indicators. By analyzing JIN MEDICAL's financials, quarterly and monthly indicators, and their related drivers, we attempt to find the most accurate representation of JIN MEDICAL's intrinsic value. As compared to an absolute model, our relative valuation model uses a comparative analysis of JIN MEDICAL. We calculate exposure to JIN MEDICAL's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of JIN MEDICAL's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 7.8 M | 7.2 M | |
| Pretax Profit Margin | 0.16 | 0.19 | |
| Operating Profit Margin | 0.17 | 0.18 | |
| Net Profit Margin | 0.15 | 0.17 | |
| Gross Profit Margin | 0.39 | 0.37 |
JIN MEDICAL Quarterly Retained Earnings |
|
JIN MEDICAL Growth Indicators
Investing in growth stocks can be very risky. If the company such as JIN MEDICAL does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 7.3 M | |
| Quarterly Earnings Growth Y O Y | -0.122 |
JIN MEDICAL Current Valuation Indicators
JIN MEDICAL's valuation analysis is a process of estimating the intrinsic value of all assets and outstanding equities. There are different methodologies and models we use to develop the final JIN MEDICAL's valuation. The techniques such as discounted cash flow and fundamental indicators such as book value per share or market capitalization are well known and widely used across most financial advisers and money managers.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as JIN MEDICAL, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use JIN MEDICAL's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes JIN MEDICAL's worth.When determining whether JIN MEDICAL INTERNATIONAL is a strong investment it is important to analyze JIN MEDICAL's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact JIN MEDICAL's future performance. For an informed investment choice regarding JIN Stock, refer to the following important reports: Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in JIN MEDICAL INTERNATIONAL. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of JIN MEDICAL. If investors know JIN will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about JIN MEDICAL listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.12) | Earnings Share 0.02 | Revenue Per Share 0.129 | Quarterly Revenue Growth 0.03 | Return On Assets 0.0403 |
The market value of JIN MEDICAL INTERNATIONAL is measured differently than its book value, which is the value of JIN that is recorded on the company's balance sheet. Investors also form their own opinion of JIN MEDICAL's value that differs from its market value or its book value, called intrinsic value, which is JIN MEDICAL's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because JIN MEDICAL's market value can be influenced by many factors that don't directly affect JIN MEDICAL's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between JIN MEDICAL's value and its price as these two are different measures arrived at by different means. Investors typically determine if JIN MEDICAL is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, JIN MEDICAL's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.